BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 30406969)

  • 1. Local regression and control of T1-2 nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.
    Xue F; Ou D; Hu C; He X
    Cancer Med; 2018 Dec; 7(12):6010-6019. PubMed ID: 30406969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes and prognostic factors of 695 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.
    Wang W; Feng M; Fan Z; Li J; Lang J
    Biomed Res Int; 2014; 2014():814948. PubMed ID: 25162028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical course of longer than five years after definitive radiotherapy for nasopharyngeal carcinoma.
    Doi H; Ri A; Inada M; Tatsuno S; Uehara T; Matsuura T; Ishikawa K; Nakamatsu K; Hosono M; Nishimura Y
    Int J Clin Oncol; 2023 Dec; 28(12):1607-1615. PubMed ID: 37798414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distant metastasis risk and patterns of nasopharyngeal carcinoma in the era of IMRT: long-term results and benefits of chemotherapy.
    Li AC; Xiao WW; Shen GZ; Wang L; Xu AA; Cao YQ; Huang SM; Lin CG; Han F; Deng XW; Zhao C
    Oncotarget; 2015 Sep; 6(27):24511-21. PubMed ID: 26087194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of regional lymph lode metastasis in unilateral nasopharyngeal carcinoma and the suggestions for selective prophylactic irradiation with intensity-modulated radiotherapy.
    Lin F; Qiu Z; Xie D; Zhou X; Wang L; Wu Z; Cheng W; Lyu S; Su Y; Tao Y
    Cancer Med; 2023 Nov; 12(21):20511-20520. PubMed ID: 37881136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging of swallowing-related structures in nasopharyngeal carcinoma patients receiving IMRT: Longitudinal dose-response characterization of quantitative signal kinetics.
    Messer JA; Mohamed AS; Hutcheson KA; Ding Y; Lewin JS; Wang J; Lai SY; Frank SJ; Garden AS; Sandulache V; Eichelberger H; French CC; Colen RR; Phan J; Kalpathy-Cramer J; Hazle JD; Rosenthal DI; Gunn GB; Fuller CD
    Radiother Oncol; 2016 Feb; 118(2):315-22. PubMed ID: 26830697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elderly nasopharyngeal carcinoma patients (aged ≥70 years): Survival and treatment strategies.
    Yang G; Huang J; Sun J; Wang L
    Cancer Med; 2023 Oct; 12(19):19523-19529. PubMed ID: 37724570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation-induced nasopharyngeal ulcers after re-irradiation with intensity-modulated radiotherapy in locoregional recurrent nasopharyngeal carcinoma patients: a dose-volume-outcome analysis.
    Ni MS; Kong FF; Pan GS; Du CR; Zhai RP; Hu CS; Ying HM
    Eur Arch Otorhinolaryngol; 2024 Mar; 281(3):1425-1434. PubMed ID: 37995006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation and analysis of risk factors of hearing impairment for nasopharyngeal carcinoma treated using intensity-modulated radiotherapy.
    Chen L; Li J; Li K; Hu J; Li Q; Huang C; Wang G; Liu N; Tang L
    Radiother Oncol; 2024 Jan; 190():109985. PubMed ID: 37926330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical treatment and prognosis of recurrent and radiotherapy insensitive nasopharyngeal carcinoma.
    Zhao Y; Fang J; Zhong Q; Zhang J; Chen J; Hou L; Wang R
    Braz J Otorhinolaryngol; 2024; 90(2):101366. PubMed ID: 38134866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid V40 is a good predictor for subclinical hypothyroidism in patients with nasopharyngeal carcinoma after intensity modulated radiation therapy: a randomized clinical trial.
    Xu Y; Peng H; Su G; Cheng Y; Guo Q; Guo L; Peng XE; Ke J
    Radiat Oncol; 2023 Aug; 18(1):141. PubMed ID: 37626342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic variables for temporal lobe injury after intensity modulated-radiotherapy of nasopharyngeal carcinoma.
    Feng M; Huang Y; Fan X; Xu P; Lang J; Wang D
    Cancer Med; 2018 Mar; 7(3):557-564. PubMed ID: 29473319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic surgery versus intensity-modulated radiotherapy in locally advanced recurrent nasopharyngeal carcinoma: a multicenter, case-matched comparison.
    Liu Y; Huang N; Gao J; He B; Huang H; Wan L; Cai Q; Zhu Z; Zhou S; Wang J; Wang X; Qiu Q; Han F
    J Otolaryngol Head Neck Surg; 2023 Nov; 52(1):72. PubMed ID: 37932841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life in patients with nasopharyngeal carcinoma receiving IMRT vs IMPT: a multicenter prospective longitudinal study.
    Chung CF; Huang BS; Wang YM; Huang YT; Chen SC
    Support Care Cancer; 2024 Mar; 32(3):203. PubMed ID: 38430411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-domain neurocognitive impairment following definitive intensity-modulated radiotherapy for nasopharyngeal cancer: A cross-sectional study.
    Chow JCH; Lee J; Lai MMP; Li S; Lau AMC; Ng BSY; Leung GGG; Li STY; Lui JCF; Cheung KM; Au KH; Wong KH; Lau AYL; Zee BCY
    Radiother Oncol; 2024 Apr; 193():110143. PubMed ID: 38341098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of stage III-IV nasopharyngeal carcinomas by external beam irradiation and local low doses of IL-2.
    Jacobs JJ; Hordijk GJ; Jürgenliemk-Schulz IM; Terhaard CH; Koten JW; Battermann JJ; Den Otter W
    Cancer Immunol Immunother; 2005 Aug; 54(8):792-8. PubMed ID: 15627211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic Change of Amide Proton Transfer Imaging in Irradiated Nasopharyngeal Carcinoma and Related Histopathological Mechanism.
    Song Q; Chen P; Chen X; Sun C; Wang J; Tan B; Liu H; Cheng Y
    Mol Imaging Biol; 2021 Dec; 23(6):846-853. PubMed ID: 33876335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Nutritional Intervention on the Management of Radiotherapy and Chemotherapy for Nasopharyngeal Carcinoma.
    Tang F; Wang P; Ye Y
    Nutr Cancer; 2024; 76(1):114-120. PubMed ID: 38082551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central nervous system metastases: a rare presentation of nasopharyngeal carcinoma.
    Abrar S; Ali N; Qureshi BM; Tahseen R
    BMJ Case Rep; 2021 Aug; 14(8):. PubMed ID: 34404660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemoglobin-to-platelet ratio in predicting the incidence of trismus after concurrent chemoradiotherapy.
    Somay E; Yilmaz B; Topkan E; Kucuk A; Haksoyler V; Pehlivan B; Selek U; Araz K
    Oral Dis; 2023 Oct; 29(7):2962-2970. PubMed ID: 36038508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.